On this page
In this issue
FDA & US regulatory
Letters, guidance, enforcement
CISA KEV & CVEs
Vulnerabilities in your SBOM
Standards & international
AAMI, ISO, IEC, EU MDCG
What to do this week
Concrete actions for security leads
Key Takeaways
- A MAUDE report for Philips IntelliSpace Cardiovascular revealed a flaw where thick client software bypasses security controls.
- InterSystems IRIS for Health was found to lack encryption for sensitive credentials during transmission.
- Manufacturers using InterSystems frameworks for diagnostic imaging face heightened risks of unauthorized system access.
- The FDA's February 3, 2026 guidance recommends current security architecture views and SBOMs.
- Section 524B of the FD&C Act requires makers to have plans to monitor and address postmarket vulnerabilities.
This week, critical architectural vulnerabilities were identified in enterprise imaging systems and data frameworks, including a direct database access flaw in the Philips IntelliSpace Cardiovascular platform. Additionally, InterSystems IRIS for Health was flagged for transmitting sensitive credentials without encryption, creating immediate risks for diagnostic imaging and interoperability platforms.
The medical device security landscape continues to face challenges related to legacy architectural choices and improper data handling. The recent reports highlight that even established platforms can harbor significant risks if security controls are bypassed by client software or if sensitive data is transmitted in the clear.
For manufacturers, these findings emphasize the necessity of maintaining a secure system architecture as outlined in the FDA's February 3, 2026 premarket cybersecurity guidance. Ensuring that diagnostic workstations and data frameworks do not allow unauthorized bulk data manipulation or credential interception is vital for patient safety and regulatory compliance.
In this brief
- Why This Matters
- Architectural Flaw in Philips IntelliSpace Cardiovascular
- Credential Interception Risk in InterSystems IRIS for Health
- What to do this week
- FAQ
Why This Matters
Security leads must recognize that architectural vulnerabilities can lead to uncontrolled risks, which requires specific notification and remediation timelines under the FDA's 2016 guidance. When software clients connect directly to databases or fail to encrypt credentials, the resulting risk of unauthorized data manipulation or system access can compromise entire clinical environments and patient data integrity.
Architectural Flaw in Philips IntelliSpace Cardiovascular
A MAUDE adverse event report regarding Philips Medical Systems Nederland B.V.
Credential Interception Risk in InterSystems IRIS for Health
An advisory for InterSystems IRIS for Health has identified a flaw involving the lack of encryption for sensitive credentials.
What to do this week
- Audit all thick client diagnostic software to ensure no direct database connections exist that bypass application-level security controls.
- Review the InterSystems IRIS for Health advisory and cross-reference your SBOM to identify any affected diagnostic or interoperability products.
- Update your postmarket vulnerability plan to ensure it includes specific timelines for customer notification and remediation as per the FDA's 2016 postmarket guidance.
How Blue Goat Cyber Helps
Blue Goat Cyber provides specialized support for medical device manufacturers navigating complex security requirements. Our team, led by experts like Christian Espinosa, assists in developing security architecture views and vulnerability disclosure plans. For more information on our approach to medical device security, visit our services page.
FAQ
Get the next issue
Stay informed on the latest medical device security updates by subscribing to the Goat's Weekly.